Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

306-94-5 - Perfluoro(decahydronaphthalene), cis + trans, 95% - Octadecafluoro(decahydronaphthalene) - Octadecafluorodecalin - A18288 - Alfa Aesar

A18288 Perfluoro(decahydronaphthalene), cis + trans, 95%

CAS-Nummer
306-94-5
Synonyme
Octadecafluoro(decahydronaphthalene)
Octadecafluorodecalin

Größe Preis ($) Menge Verfügbarkeit
25g 34,61
100g 132,87
500g 530,45
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Perfluoro(decahydronaphthalene), cis + trans, 95%

MDL
MFCD00010626
EINECS
206-192-4

Chemische Eigenschaften

Formel
C10F18
Molmasse
462.10
Schmelzpunkt
-10 to -7°
Siedepunkt
141-142°
Dichte
1.940
Brechungsindex
1.3145
Löslichkeit
Insoluble in water.

Anwendungen

Perfluoro(decahydronaphthalene) is used to dissolve gases. Due to its gas carrying capacity, it is utilized to increase oxygen delivery during cell culture. It acts as an ingredient in fluosol which is an artificial blood product. It is also used to dissolve Teflon.

Bemerkungen

Incompatible with strong oxidizing agents.

Literaturverweise

The ability of perfluorinated solvents to solubilize gases, together with their unique phase properties, have been exploited in a system for oxidation of aldehydes to acids, sulfides to sulfoxides and sulfones, and alkenes to epoxides. The reactions are carried out in the presence of dissolved O2, using a transition metal (Ru, Ni) catalyst with perfluorinated ligands, in a perfluoro(decahydronaphthalene)/toluene solvent mixture under monophasic conditions at 64oC. On cooling, phase separation takes place, enabling the product to be isolated from the toluene phase, and the catalyst system to be recycled in the fluorous phase: Angew. Chem. Int. Ed., 36, 1454 (1997).

Trindade, A. C.; De Figueiredo, J. A. P.; Steier, L.; Weber, J. B. B. Photodynamic Therapy in Endodontics: A Literature Review. Photomed. Laser Surg. 2015, 33 (3), 175-182.

George, S.; Kishen, A. Augmenting the antibiofilm efficacy of advanced noninvasive light activated disinfection with emulsified oxidizer and oxygen carrier. J. Endod. 2008, 34 (9), 1119-1123.

Weitere Referenzen

Merck
14,4183
Beilstein
2067113
Harmonized Tariff Code
2903.89
TSCA
Yes
RTECS
QJ3175000

Empfohlen

  • A10530

    7-Aminocephalosporanic acid, 98% (dry wt.), may cont. up to 2% water
  • A10714

    5,5-Dimethyloxazolidine-2,4-dione, 99%
  • A10830

    (±)-1-Phenyl-1-propanol, 98+%
  • L16042

    Diethyl difluoromalonate, 97%
  • 15812

    Perfluorohexanes, 98+%

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf